2013-11-05T08:53:18-06:00 2013-06-30 381337372 BEENE GARTER LLP 56 GRANDVILLE AVE SW SUITE 100 GRAND RAPIDS MI 495034036 990 2012-07-01 381550001 MICHIGAN BLOOD MICH 6167742300 PO BOX 1704 GRAND RAPIDS MI 495011704 WILLIAM RIETSCHA 6167742300 2013-10-24 1 MARGARET W BISHOP CPA P00295096 6162355200 2012 2016-03-07 17:11:31Z WILLIAM RIETSCHA PO BOX 1704 GRAND RAPIDS MI 495011704 47084015 0 X WWW.MIBLOOD.ORG X 1955 MI HELPING PEOPLE MAKE A LIFESAVING DIFFERENCE THROUGH BLOOD PRODUCTS AND SERVICE EXCELLENCE 13 12 534 552 0 0 62335 97964 41063808 40481179 306406 296574 6825 8018 41439374 40883735 46575 0 0 0 18943703 19003516 0 0 0 22486069 21739467 41476347 40742983 -36973 140752 29624512 29672711 3842689 3388798 25781823 26283913 X THE PURPOSE OF MICHIGAN BLOOD IS TO PROVIDE A SAFE AND ADEQUATE BLOOD SUPPLY AND BLOOD-RELATED SERVICES FOR THE COMMUNITIES SERVED BY HOSPITAL PARTNERS THROUGHOUT THE STATE. MICHIGAN BLOOD IS THE SOLE PROVIDER OF BLOOD FOR 39 HOSPITAL FACILITIES. THESE HOSPITALS INCLUDE MAJOR MEDICAL CENTERS (SECONDARY- AND TERTIARY-CARE TEACHING FACILITIES) SERVING POPULATIONS TOTALING MORE THAN 2.25 MILLION PEOPLE. THROUGH DONOR CENTERS AND BLOOD DRIVES IN NORTHWEST, EAST-CENTRAL, WEST, AND SOUTHWEST MICHIGAN, MICHIGAN BLOOD RECRUITS AND COLLECTS BLOOD FROM VOLUNTEER DONORS TO ACHIEVE ITS LIFESAVING MISSION. ANNUALLY, MICHIGAN BLOOD COLLECTS APPROXIMATELY 127,000 UNITS OF BLOOD FROM VOLUNTEER BLOOD DONORS AND DISTRIBUTES 250,000 BLOOD COMPONENTS. 0 0 36907927 40481179 ALLOGENEIC WHOLE-BLOOD DONATIONVOLUNTEER DONORS GIVE BLOOD AT DRIVES HOSTED BY COMMUNITY BUSINESSES AND ORGANIZATIONS AND AT NINE PERMANENT DONOR CENTERS THROUGHOUT MICHIGAN BLOOD'S SERVICE AREA. SEE WWW.MIBLOOD.ORG FOR A COMPREHENSIVE LIST OF LOCATIONS.AUTOLOGOUS AND DIRECTED DONATION (DETAILS)BLOOD DONATIONS FOR ONE'S OWN PLANNED USE FOR ELECTIVE SURGERY, OR FOR ANOTHER SPECIFIC PERSON ARE ACCEPTED WITH DOCTOR'S ORDER.DONORS WITH HEMOCHROMATOSIS (DETAILS)MICHIGAN BLOOD HOLDS AN FDA VARIANCE TO ALLOW DONORS WITH HEMOCHROMATOSIS (A GENETIC ILLNESS CAUSING THE OVERPRODUCTION OF RED BLOOD CELLS AND IRON) TO DONATE FOR THE VOLUNTEER BLOOD SUPPLY IF OTHERWISE ELIGIBLE.APHERESIS DONATION (DETAILS)SPECIAL APHERESIS EQUIPMENT MAKES IT POSSIBLE TO COLLECT ONE OR MORE SPECIFIC BLOOD COMPONENTS, WHILE RETURNING THE REMAINDER TO THE DONOR. APHERESIS ALLOWS A DONOR TO GIVE A GREATER QUANTITY OF ONE COMPONENT THAN IS POSSIBLE DURING STANDARD WHOLE BLOOD DONATION. THESE LARGER SPECIAL COMPONENTS CAN HELP REDUCE THE NUMBER OF DIFFERENT DONORS TO WHICH A PATIENT IS EXPOSED. THERAPEUTIC APHERESIS (DETAILS)PATIENTS WITH DISEASES SUCH AS TTP, KIDNEY REJECTION, MYASTHENIA GRAVIS, SICKLE CELL DISEASE, OR LEUKEMIA CAN BE TREATED BY THE REMOVAL OF ONE OR MORE BLOOD COMPONENTS USING APHERESIS TECHNOLOGY. MICHIGAN BLOOD STAFF AND EQUIPMENT TRAVEL TO GRAND RAPIDS AREA HOSPITALS TO MAKE THIS SERVICE AVAILABLE AS NEEDED.BLOOD BUS (DETAILS)EACH MICHIGAN BLOOD REGION OPERATES A SELF-CONTAINED DONOR CENTER ON WHEELS. BLOOD BUSES EXPAND OUTREACH INTO SMALL COMMUNITIES IN SPARSELY POPULATED AREAS. IN URBAN AREAS, THE BLOOD BUSES ENABLE BLOOD DRIVE SPONSORSHIP BY GROUPS THAT LACK ON-SITE SPACE OR PERSONNEL TO HOST CONVENTIONAL BLOOD DRIVES. STEM CELL/CORD BLOOD BANK (DETAILS)MICHIGAN BLOOD CORD BLOOD BANK, THE FIRST OF ITS KIND IN MICHIGAN, HAS COLLECTED AND STORED BLOOD FROM MORE THAN 3,644 UMBILICAL CORDS. CORD BLOOD IS RICH IN STEM CELLS AND CORD BLOOD TRANSPLANTATION IS FINDING INCREASING APPLICATION IN CHILDREN AND ADULTS AROUND THE GLOBE SUFFERING FROM CERTAIN LIFE-THREATENING DISEASES. LOCAL AVAILABILITY OF STEM CELL COLLECTION, PROCESSING, STORAGE, AND PRE-TRANSPLANT PREPARATION SUPPORTS THE LOCAL TRANSPLANT PROGRAM'S ABILITY TO OFFER ADVANCED MEDICAL CARE. IT ALSO OFFERS INCREASED CONVENIENCE AND REDUCED STRESS FOR PATIENTS AND FAMILIES WHO PREVIOUSLY HAD TO TRAVEL LONG DISTANCES FOR TRANSPLANT SERVICES. CELLULAR THERAPY (DETAILS)MICHIGAN BLOOD COLLECTS MONONUCLEAR CELLS FROM PROSTATE CANCER PATIENTS TO BE PREPARED BY DENDREON INTO A PERSONALIZED "CANCER VACCINE." OTHER APPLICATIONS OF THIS CELLULAR THERAPY ARE IN THE RESEARCH AND APPROVAL PROCESS. MICHIGAN BLOOD ALSO COLLECTS AND PROCESSES PATIENT WHITE CELLS WITH UV LIGHT TO HELP TREAT GRAFT VS. HOST DISEASE AND CUTANEOUS T-CELL LYMPHOMA.DNA/HLA (DETAILS)THIS LABORATORY USES SPECIAL TECHNIQUES TO CONDUCT TISSUE-TYPING AT THE GENETIC CODE LEVEL TO EVALUATE DONOR-PATIENT COMPATIBILITY BEFORE TRANSPLANTATION. LOCAL AVAILABILITY OF THESE SERVICES HELPS DOCTORS RESPOND FASTER TO URGENT PATIENT NEEDS CAUSED BY AGGRESSIVE DISEASES. MICHIGAN BLOOD LABORATORY SERVICES CAN PROVIDE KEY INFORMATION IN JUST THREE TO FOUR DAYS; USING A DISTANT LAB SERVICE MAY MEAN WAITING SEVERAL WEEKS FOR THE SAME DATA. PATIENTS WITH TRANSFUSION/PREGNANCY-RELATED SENSITIVITIES ALSO BENEFIT FROM THE SERVICES OF THE DNA/HLA LABORATORY WHICH HELPS PHYSICIANS DIAGNOSE, TREAT AND FIND APPROPRIATE BLOOD PRODUCTS. THE DNA/HLA LABORATORY ALSO TYPES PLATELET APHERESIS DONORS TO IDENTIFY LIFE-SAVING MATCHES FOR PATIENTS NEEDING TRANSFUSION.RED CELL REFERENCE LABORATORY (DETAILS)PATIENTS WITH COMPLEX TRANSFUSION-RELATED SENSITIVITIES BENEFIT FROM THE SERVICES OF THE RED CELL REFERENCE LABORATORY, WHICH PROVIDES INFORMATION THAT HELPS PHYSICIANS DIAGNOSE AND TREAT COMPLICATED CASES AND FIND RARE BLOOD TYPES FOR TRANSFUSION. THESE PATIENTS OFTEN ARE CRITICALLY ILL AND MAY SUFFER SERIOUS COMPLICATIONS (INCLUDING DEATH) WITHOUT SPECIAL LABORATORY SERVICES TO HELP THEIR DOCTORS ASSESS THE RISKS OF TRANSFUSION REACTIONS AND DONOR/RECIPIENT INCOMPATIBILITIES. INFECTIOUS DISEASE TESTING LABORATORYMICHIGAN BLOOD IS RESPONSIBLE FOR TESTING ITS BLOOD DONATIONS FOR INFECTIOUS DISEASES. THIS IS ACCOMPLISHED THROUGH A COMBINATION OF IN-HOUSE AND THIRD PARTY TESTING.MARROW PROGRAM (DETAILS)IN THE PAST 20 YEARS, MICHIGAN BLOOD MARROW/STEM CELL PROGRAM HAS ESTABLISHED ONE OF THE PREMIER DONOR-RECRUITMENT RECORDS IN THE UNITED STATES, ADDING MORE THAN 56,000 INDIVIDUALS WITH ADVANCED TISSUE TYPING TO THE REGISTRY OF POTENTIAL STEM CELL DONORS MAINTAINED BY THE BE THE MATCH REGISTRY (NATIONAL MARROW DONOR PROGRAM). IN 2010, THE DONOR CENTER RECEIVED THE DONOR MANAGEMENT RECOGNITION AWARD, A LIFETIME ACHIEVEMENT AWARD. THE MARROW/STEM CELL PROGRAM ALSO PROVIDES SUPPORT SERVICES FOR PATIENTS AND FAMILIES SEEKING COMPATIBLE STEM CELL DONORS. STEM CELL TRANSPLANTS REMAIN THE PRIMARY SOURCE OF HOPE FOR PATIENTS WITH CERTAIN KINDS OF LIFE-THREATENING DISEASES. MICHIGAN BLOOD HAS PROVIDED LIFE-SAVING STEM CELL TRANSPLANTS FOR MORE THAN 600 PEOPLE AROUND THE WORLD.VOLUNTEER OPPORTUNITIES (DETAILS)MICHIGAN BLOOD OFFERS A WIDE VARIETY OF OPPORTUNITIES FOR COMMUNITY MEMBERS INTERESTED IN VOLUNTEERING THEIR TIME TO HELP THEIR COMMUNITY. RESPONSIBILITIES RANGE FROM PREPARING MAILINGS TO SERVING REFRESHMENTS AT BLOOD DRIVES.WEBSITE (DETAILS)SINCE 1998 MICHIGAN BLOOD HAS POSTED A WEBSITE, WWW.MIBLOOD.ORG, WHICH IS UPDATED DAILY BY THE COMMUNICATIONS & MARKETING DEPARTMENT. IT INCLUDES A DESCRIPTION OF MICHIGAN BLOOD'S MISSION AND SERVICES, PLUS INFORMATION ABOUT RECENT AND COMING EVENTS, STORIES ABOUT BLOOD DONORS AND RECIPIENTS, SCHEDULES OF MOBILE BLOOD DRIVES IN ALL REGIONS, EMPLOYMENT POSTINGS, AND REFERENCE INFORMATION ABOUT BLOOD, BLOOD SAFETY, AND BLOOD DONATION. THE WEBSITE HAS PROVED TO BE A VALUABLE AND POPULAR RESOURCE FOR PUBLIC INFORMATION AND EDUCATION, PARTICULARLY FOR STUDENTS AND OTHERS WHO WANT TO LEARN ABOUT THEIR COMMUNITY BLOOD BANK. IT ALSO PROVIDES A UNIQUE VENUE FOR HONORING DONORS AND SUPPORTERS. ALSO, MICHIGAN BLOOD REGULARLY COMMUNICATES VIA ONLINE SOCIAL MEDIA INCLUDING FACEBOOK, TWITTER, YOUTUBE, AND INSTAGRAM, TO PUBLICIZE AND DOCUMENT MICHIGAN BLOOD EVENTS AND ACTIVITIES, AND TO STIMULATE TRAFFIC TO MICHIGAN BLOOD'S WEBSITE; AND TO RESPOND TO A WIDE VARIETY OF INQUIRIES AND COMMENTS. 36907927 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 37 0 1 534 1 0 0 0 0 0 1 1 0 0 0 0 X 13 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MI X CHARLEEN MELLO 6162338613 1036 FULLER NE GRAND RAPIDS MI 49503 CHUCK DOWNEY 0.30 X 0 0 0 ROCKY S LOVE 0.30 X 0 0 0 DARRYL V NELSON 0.20 X 0 0 0 JOHN J PERRAS 0.50 X X 0 0 0 DAVID J SMITH 0.30 X 0 0 0 PAUL D SMITH 0.50 X X 0 0 0 C EUGENE SOECHTIG DO 0.20 X 0 0 0 WILLIAM J RIETSCHA 40.00 X X 256141 0 26151 NICHOLAS V KROEZE 0.30 X 0 0 0 JOHN O'DONNELL MD 0.30 X 0 0 0 MITCH WATT 0.30 X 0 0 0 LINDA CONSTANTINO 0.30 X 0 0 0 PAT HOWE 0.20 X 0 0 0 CHARLEEN C MELLO 40.00 X 93049 0 10565 LEE ANN WEITEKAMP 40.00 X 274229 0 24961 MARK PALKOWSKI 40.00 X 162713 0 24923 TAMMON NASH 40.00 X 157400 0 19455 JIM CHILDRESS 40.00 X 118622 0 12789 MAGGIE GROGGEL 40.00 X 103378 0 16776 1165532 0 135620 6 0 1 0 0 8413 89551 25000 97964 BLOOD PRODUCTS/TESTING 900099 36597247 36597247 SPECIAL SERVICES 900099 3883932 3883932 40481179 319140 319140 5857157 307980 5773267 414436 83890 -106456 -22566 -22566 20595 8413 12577 8018 8018 40883735 40481179 0 304592 433909 433909 14438630 12909699 1528931 624377 552706 71671 2417826 2242335 175491 1088774 970077 118697 18468 18468 22266 500 21766 38256 38256 167998 109085 58913 257784 48104 209680 641779 464772 177007 997992 997992 492026 435888 56138 54161 30204 23957 1317251 1111276 205975 182463 164623 17840 BLOOD PRODUCT SUPPLIES 13786821 13776072 10749 0 OUTSIDE LAB SERVICES 1599819 1593370 6449 REPAIRS AND MAINTENANCE 1290377 919650 370727 MISCELLANEOUS 751102 556658 194444 120904 24916 95988 40742983 36907927 3835056 0 1943155 2121760 735 270 4147967 4171717 1805748 1640903 409045 425192 25215818 16336696 9760331 8879122 11099473 12017856 458058 415891 29624512 29672711 3842689 3388798 3842689 3388798 X 25761675 26264659 9998 9104 10150 10150 25781823 26283913 29624512 29672711 140752 361338 0 X X 0 1 X 1 0 X 144421 95296 51713 62335 97964 451729 32278641 45490610 37517215 41063808 40481179 196831453 32423062 45585906 37568928 41126143 40579143 197283182 0 0 0 197283182 510987 588876 435289 276187 319140 2130479 510987 588876 435289 276187 319140 2130479 24882 13104 18356 18173 20595 95110 32958931 46187886 38022573 41420503 40918878 199508771 0.98880 0.98760 0.01070 0.01200 X SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: PART III, SECTION B, LINE 12: OTHER INCOME INCLUDES SPECIAL EVENT GROSS REVENUE RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2546071 2546071 10665483 6411390 4254093 259037 222657 36380 9764015 7925128 1838887 1981212 1777521 203691 8879122 MUTUAL FUNDS 11197371 F EQUITY SECURITIES 656038 F MONEY MARKET ACCOUNTS 164447 F 12017856 X 41260282 361338 15209 376547 40883735 0 40883735 40758192 15209 15209 40742983 0 40742983 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: THE INTERNAL REVENUE SERVICE HAS DETERMINED THE ORGANIZATION TO BE EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE WHEREBY ONLY UNRELATED BUSINESS INCOME, AS DEFINED BY SECTION 509(A)(1) OF THE CODE, IS SUBJECT TO FEDERAL INCOME TAX. THE ORGANIZATION CURRENTLY HAS NO UNRELATED BUSINESS ACTIVITY. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED. IN ADDITION, THE ORGANIZATION QUALIFIES FOR CHARITABLE CONTRIBUTION DEDUCTIONS AND HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION UNDER SECTION 509(A)(2). TAX POSITIONS TAKEN ARE ASSESSED FOR UNCERTAINTY AND A PROVISION MAY BE RECORDED IF A TAX POSITION IS NOT LIKELY TO BE SUSTAINED UPON EXAMINATION. WITH LIMITED EXCEPTIONS, THE ORGANIZATION IS NO LONGER SUBJECT TO AUDITS BY FEDERAL AUTHORITIES FOR YEARS PRIOR TO 2009. GOLF OUTING 29008 8413 20595 12577 29008 8413 20595 12577 12577 8018 X X X 0 1 0 0 0 0 0 1 0 WILLIAM J RIETSCHA 218105 0 0 0 38036 0 15368 0 14775 0 286284 0 0 0 LEE ANN WEITEKAMP 251287 0 0 0 22942 0 16454 0 14287 0 304970 0 0 0 MARK PALKOWSKI 151006 0 0 0 11707 0 9763 0 20581 0 193057 0 0 0 TAMMON NASH 146684 0 0 0 10716 0 9444 0 15536 0 182380 0 0 0 PART I, LINE 4B WILLIAM J. RIETSCHA $16,500 PART I, LINE 7 NON FIXED PAYMENTS WERE MADE FOR PERFORMANCE BASED RETENTION BONUSES FORM 990, PART VI, SECTION B, LINE 11 FORM 990 IS FORMALLY REVIEWED BY THE FINANCE/AUDIT COMMITTEE AND APPROVED BY THE BOARD OF DIRECTORS BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY CONFLICT OF INTEREST STATEMENTS ARE COMPLETED BY ALL BOARD OF DIRECTORS AND MEMBERS OF THE MANAGEMENT TEAM. RESPONSES ARE COMPILED BY THE EXECUTIVE ASSISTANT/DELEGATE. BOARD OF DIRECTOR RESPONSES ARE REVIEWED BY THE GOVERNANCE COMMITTEE AND ALSO THE FULL BOARD OF DIRECTORS. MANAGEMENT TEAM RESPONSES ARE REVIEWED BY THE CEO/PRESIDENT. FORM 990, PART VI, SECTION B, LINE 15 FORM 990, PART VI, SECTION B, LINE 15: LINE 15A: A THIRD PARTY EXECUTIVE COMPENSATION CONSULTANT IS ENGAGED ANNUALLY TO ANALYZE AT LEAST FIVE SURVEYS THAT ARE USED TO MAKE UP THE COMPONENTS THAT DEFINE RANGES FOR THE CEO AND EACH OF THE THREE VP POSITIONS. THE CONSULTANT REVIEWS CURRENT PRACTICE AND ADVISES OUR NEAR TERM APPROACH TO COMPA-RATIO, BASE SALARY INCREASES, AND VARIABLE INCREASES BASED ON A VARIETY OF FACTORS INCLUDING CONTEMPORARY PRACTICES IN HEALTHCARE, BLOODBANKING, AND EVEN BROADER BUSINESS MARKETS. THE HR/COMPENSATION BOARD COMMITTEE REVIEWS MATERIAL FROM THE CONSULTANT. THE COMMITTEE RECOMMENDS COMPENSATION ACTIONS AT THE CEO LEVEL IN THE SUMMER, FOLLOWING THE CONCLUSION OF THE FISCAL YEAR. CEO COMPENSATION IS APPROVED BY THE BOARD OF DIRECTORS FOLLOWING THE SUMMER HR/COMP MEETING. FORM 990, PART VI, SECTION B, LINE 15: 15B: THE THIRD PARTY EXECUTIVE COMPENSATION CONSULTANT IS ENGAGED TO ANALYZE AT LEAST FIVE SURVEYS THAT ARE USED TO MAKE UP THE COMPONENTS THAT DEFINE RANGES FOR THE THREE VP POSITIONS. THE CONSULTANT REVIEWS CURRENT PRACTICE AND ADVISES OUR APPROACH TO COMPA-RATIO, BASE SALARY INCREASES, AND VARIABLE INCREASES BASED ON A VARIETY OF FACTORS INCLUDING CONTEMPORARY PRACTICES IN HEALTHCARE, BLOODBANKING, AND EVEN BROADER MARKETS. THE HR/COMPENSATION BOARD COMMITTEE REVIEWS THE DATA EACH SPRING, AND APPROVES THE DESIGN OF THE VP INCENTIVE COMPENSATION PLAN AT THAT TIME. THE CEO AUTHORIZES VP LEVEL COMPENSATION ACTIONS. THE COMMITTEE VALIDATES THE VP LEVEL COMPENSATION ACTIONS AT THE SUMMER MEETING, FOLLOWING THE CONCLUSION OF THE FISCAL YEAR. FOR OTHER KEY EMPLOYEES, A SEPARATE COMPENSATION CONSULTANT IS ENGAGED TO PROVIDE MARKET DATA AND RECOMMENDATIONS FOR PAY RANGES FOLLOWING REVIEW OF THE JOB DESCRIPTIONS AGAINST SUCH DATA. FULL MARKET REVIEW THROUGH HUMAN RESOURCES, CEO, AND VP OF TECH OPS OCCURS AT LEAST EVERY THREE YEARS. AD HOC REVIEW OCCURS THROUGH HUMAN RESOURCES STAFF AND CEO AGAINST INDUSTRY AND GEOGRAPHIC SURVEYS HOUSED AT MICHIGAN BLOOD - ABC COMPENSATION SURVEY, MIDWEST COMPDATA SURVEY, AND TEA WEST MICHIGAN SURVEY, AS EXAMPLES. FORM 990, PART VI, SECTION C, LINE 19 MICHIGAN BLOOD MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C COMMITTEE RESPONSIBLE FOR THE AUDIT: AS IN PRIOR YEARS, THE ORGANIZATION'S FINANCE/AUDIT COMMITTEE IS RESPONSIBLE FOR THE OVERSIGHT OF THE AUDIT.